참고문헌
- Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M., and Issa, J.P. (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72, 141-196
- Brown, R. and Strathdee, G. (2002). Epigenomics and epigenetic therapy of cancer. Trends Mol. Med. 8, S43-S48 https://doi.org/10.1016/S1471-4914(02)02314-6
- Costello, J.F., Fruhwald, M.C., Smiraglia, D.J., Rush, L.J., Robertson, G.P., et al. (2000). Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nat. Genet. 24, 132-138 https://doi.org/10.1038/72785
- Cho, M., Konishi, N., Yamamoto, K., Inui, T., Kitahori, Y., Nakagawa, Y., Uemura, H., Hirao, Y., and Hiasa, Y. (1998). Genomic Aberrations in Renal Cell Carcinomas Detected by Restriction Landmark Genomic Scanning. Eur. J. Cancer. 34, 2112-2118 https://doi.org/10.1016/S0959-8049(98)00261-5
- Dai, Z., Lakshmanan, R.R., Zhu, W.G., Smiraglia, D.J., Rush, L.J., Fruhwald, M.C., Brena, R.M., Li, B., Wright, F.A., Ross, P., Otterson, G.A., and Plass, C. (2001). Global Methylation Profiling of Lung Cancer Identifies Novel Methylated Genes. Neoplasia 3, 1-10
- Dai, Z., Weichenhan, D., Wu, Y.Z., Hall, J.L., Rush, L.J., Smith, L.T., Raval, A., Yu, L., Kroll, D., Muehlisch, J., Fruhwald, M.C., de Jong, P., Catanese, J., Davuluri, R.V., Smiraglia, D.J., and Plass, C. (2002). An Asci boundary library for the studies of genetic and epigenetic alterations in CpG islands. Genome Res. 12, 1591-1598 https://doi.org/10.1101/gr.197402
- Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H., and Mukai, T. (1991). A genomic scanning method for higher organisms using restriction sites as landmark. Proc. Natl. Acad. Sci. USA 88, 9523-9527
- Hayashizaki, Y., Hirotsune, S., Okazaki, Y., Hatada, I., Shibata, H., Kawai, J., Hirose, K., Watanabe, S., Fushiki, S., and Wada, S. (1993). Restriction landmark genomic scanning method and its various applications. Electrophoresis 14, 251-258 https://doi.org/10.1002/elps.1150140145
- Jones, P.A. and Laird, P.W. (1999). Cancer epigenetics comes of age. Nat. Genet. 21, 163-167 https://doi.org/10.1038/5947
- Jones, P.A. and Baylin, S.B. (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428 https://doi.org/10.1038/nrg816
- Kim, Y.S., Yoo, H.S., Lee, K.T., Goh, S.H., Jung, J.S., Oh, S.W., Baba, M, Yasuda, T., Matsubara, K. and Nagai, H. (2000). Detection of genetic alternations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA. Int. J. Oncol. 17,297-308
- Kuick, R., Asakawa, J., Neel, J.V., Kodaira, M., Satoh, C., Thoraval, D., Gonzalez, I.L., and Hanash, S.M. (1996). Studies of the inheritance of human ribosomal DNA variants detected in two-dimensional separations of genomic restriction fragments. Genetics 144, 307-116
- Laird, P.W. (2003). The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3, 253-266 https://doi.org/10.1038/nrc1045
- Miwa, W., Yashima, K., Sekine, T., and Sekiya, T. (1995). Demethylation of a repetitive DNA sequence in human cancers. Electrophoresis 16, 227-232 https://doi.org/10.1002/elps.1150160138
- Momparler, R.L., Bouffard, D.Y., Momparler, L.F., Dionne,J., Belanger, K., and Ayoub, J. (1997). Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anticancer Drugs 8, 358-368 https://doi.org/10.1097/00001813-199704000-00008
- Nagai, H., Ponglikitmongkol, M., Mita, E., Ohmachi, Y., Yoshikawa, H., Saeki, R., Yumoto, Y., Nakanishi, T., and Matsubara, K. (1994). Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res. 54, 1545-1550
- Nakamura, M., Konishi, N.,Tsunoda, S., Hiasa,Y., Tsuzuki, T., Takemura,K., Kobitsu, K., and Sakaki,T. (1997).Genomic alterations in humanglioma cell lines detected by restriction landmark genomic scanning. J. Neurooncol. 34, 203-209 https://doi.org/10.1023/A:1005714811327
- Ohsumi, T., Okazaki, Y., Hirotsune, S., Shibata, H., Muramatsu, M., Suzuki, H., Taga, C., Watanabe, S., and Hayashizaki, Y. (1995). A spot cloning method for restriction landmark genomic scanning. Electrophoresis 16, 203-209 https://doi.org/10.1002/elps.1150160135
- Okazaki, Y., Okuizumi, H., Ohsumi, T., Nomura, O., Takada, S., Kamiya, M., Sasaki, N., Matsuda, Y., Nishimura, M., Tagaya, O., Muramatsu, M., and Hayashizaki, Y. (1996). A genetic linkage map of the Syrian hamster and localization of cardiomyopathy locus on chromosome 9qa2.1-b1 using RLGS spot-mapping. Nat. Genet. 13, 87-90 https://doi.org/10.1038/ng0596-87
- Okuizumi, H., Okazaki, Y., Ohsumi, T., Hanami, T., Mizuno, Y., Muramatsu, M., Hayashizaki, Y., Plass, C., and Chapman, V.M. (1995). A single gel analysis of 575 dominant and codominant restriction landmark genomic scanning loci in mice interspecific backcross progeny. Electrophoresis 16, 253-260 https://doi.org/10.1002/elps.1150160141
- Plass, C., Shibata, H., Kalcheva, I., Mullins, L., Kotelevtseva, N., Mullins, J., Kato, R., Sasaki, H., Hirotsune, S., Okazaki, Y., Held, W.A, Hayashizaki, Y. and Chapman, V.M (1996). Identification of Grf1 on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat. Genet. 14, 106-109 https://doi.org/10.1038/ng0996-106
- Pohlmann, P., DiLeone, L.P., Cancella, A.I., Caldas, A.P., Dal Lago, L., Campos, O.Jr., Monego, E., Rivoire, W., and Schwartsmann, G. (2002).Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix. Am. J. Clin. Oncol. 25, 496-501 https://doi.org/10.1097/00000421-200210000-00015
- Shibata, H., Yoshino, K., Muramatsu, M., Plass, C., Chapman, V.M., and Hayashizaki, Y. (1995). The use of restriction landmark genomic scanning to scan the mouse genome for endogenous loci with imprinted patterns of methylation. Electrophoresis 16, 210-217 https://doi.org/10.1002/elps.1150160136
- Smiraglia, D.J., Fruhwald, M.C., Costello, J.F., McCormick, S.P., Dai, Z., Peltomaki, P., O'Dorisio, M.S., Cavenee, W.K., and Plass, C. (1999). A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics 58, 254-262 https://doi.org/10.1006/geno.1999.5840
- Smiraglia, D.J., Rush, L.J., Fruhwald, M.C., Dai, Z., Held, W.A, Costello, J.F., Lang, J.C., Eng, C., Li, B., Wright, F.A, Caligiuri, M.A, and Plass, C. (2001). Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum. Mol. Genet. 10, 1413-1419 https://doi.org/10.1093/hmg/10.13.1413
- Smiraglia, D.J., Szymanska,J., Kraggerud, S.M., Lothe,R.A, Peltomaki, P., and Plass, C. (2002). Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21, 3909-3916 https://doi.org/10.1038/sj.onc.1205488
- Rush, L.J., Dai, Z., Smiraglia, D.J., Gao, X., Wright, F.A, Fruhwald, M., Costello, J.F., Held, W.A, Yu, L., Krahe, R., Kolitz, J.E., Bloomfield, C.D., Caligiuri, M.A, and Plass, C. (2001). Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood97, 3226-3233 https://doi.org/10.1182/blood.V97.10.3226
- Rush, L.J., Raval, A., Funchain, P., Johnson, A.J., Smith, L., Lucas, D.M., Bembea, M., Liu, T.H., Heerema, N.A., Rassenti, L., Liyanarachchi, S., Davuluri, R., Byrd, J.C., and Plass, C. (2004). Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res. 64, 2424-2433 https://doi.org/10.1158/0008-5472.CAN-03-2870
- Zardo, G., Tiirikainen, M.I., Hong, C., Misra, A., Feuerstein, B.G., Volik, S., Collins, C.C., Lamborn, K.R., Bollen, A., Pinkel, D., Albertson, D.G., and Costello, J.F. (2002). Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat.Genet. 32, 453-458 https://doi.org/10.1038/ng1007